Leptomeningeal carcinomatosis as only pathological finding at FDG-PET/CT in case of tumor marker elevation in breast cancer
Leptomeningeal carcinomatosis is an infrequent disease and although its treatment is palliative, earlier diagnosis will lead to prolonged survival and improve functional outcome. Whole-body FDG-PET allows the entire spinal cord to be examined noninvasively, so close attention should be paid to the s...
Main Authors: | , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Medknow Publications & Media Pvt Ltd
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928755/ |
id |
pubmed-3928755 |
---|---|
recordtype |
oai_dc |
spelling |
pubmed-39287552014-03-03 Leptomeningeal carcinomatosis as only pathological finding at FDG-PET/CT in case of tumor marker elevation in breast cancer Grande, Maria Luz Dominguez Rayo, Juan Ignacio Serrano, Justo Infante, Jose Rafael Garcia, Lucia Duran, Carmen Gomez-Caminero, Felipe Interesting Images Leptomeningeal carcinomatosis is an infrequent disease and although its treatment is palliative, earlier diagnosis will lead to prolonged survival and improve functional outcome. Whole-body FDG-PET allows the entire spinal cord to be examined noninvasively, so close attention should be paid to the spinal canal, since these lesions can easily be mistaken for physiologic uptake, sometimes there is no clinical suspicion and may occur without concurrent active cancer. We present a female patient with a history of carcinoma of the breast, who presented an elevation of serum tumor marker CA 15-3. An FDG-PET/CT study only revealed multiple abnormal uptake at the vertebral foramen at thoracic and lumbosacral regions suggesting leptomeningeal metastases that were confirmed by MRI and cerebrospinal fluid cytology. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC3928755/ /pubmed/24591787 http://dx.doi.org/10.4103/0972-3919.125779 Text en Copyright: © Indian Journal of Nuclear Medicine http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
repository_type |
Open Access Journal |
institution_category |
Foreign Institution |
institution |
US National Center for Biotechnology Information |
building |
NCBI PubMed |
collection |
Online Access |
language |
English |
format |
Online |
author |
Grande, Maria Luz Dominguez Rayo, Juan Ignacio Serrano, Justo Infante, Jose Rafael Garcia, Lucia Duran, Carmen Gomez-Caminero, Felipe |
spellingShingle |
Grande, Maria Luz Dominguez Rayo, Juan Ignacio Serrano, Justo Infante, Jose Rafael Garcia, Lucia Duran, Carmen Gomez-Caminero, Felipe Leptomeningeal carcinomatosis as only pathological finding at FDG-PET/CT in case of tumor marker elevation in breast cancer |
author_facet |
Grande, Maria Luz Dominguez Rayo, Juan Ignacio Serrano, Justo Infante, Jose Rafael Garcia, Lucia Duran, Carmen Gomez-Caminero, Felipe |
author_sort |
Grande, Maria Luz Dominguez |
title |
Leptomeningeal carcinomatosis as only pathological finding at FDG-PET/CT in case of tumor marker elevation in breast cancer |
title_short |
Leptomeningeal carcinomatosis as only pathological finding at FDG-PET/CT in case of tumor marker elevation in breast cancer |
title_full |
Leptomeningeal carcinomatosis as only pathological finding at FDG-PET/CT in case of tumor marker elevation in breast cancer |
title_fullStr |
Leptomeningeal carcinomatosis as only pathological finding at FDG-PET/CT in case of tumor marker elevation in breast cancer |
title_full_unstemmed |
Leptomeningeal carcinomatosis as only pathological finding at FDG-PET/CT in case of tumor marker elevation in breast cancer |
title_sort |
leptomeningeal carcinomatosis as only pathological finding at fdg-pet/ct in case of tumor marker elevation in breast cancer |
description |
Leptomeningeal carcinomatosis is an infrequent disease and although its treatment is palliative, earlier diagnosis will lead to prolonged survival and improve functional outcome. Whole-body FDG-PET allows the entire spinal cord to be examined noninvasively, so close attention should be paid to the spinal canal, since these lesions can easily be mistaken for physiologic uptake, sometimes there is no clinical suspicion and may occur without concurrent active cancer. We present a female patient with a history of carcinoma of the breast, who presented an elevation of serum tumor marker CA 15-3. An FDG-PET/CT study only revealed multiple abnormal uptake at the vertebral foramen at thoracic and lumbosacral regions suggesting leptomeningeal metastases that were confirmed by MRI and cerebrospinal fluid cytology. |
publisher |
Medknow Publications & Media Pvt Ltd |
publishDate |
2014 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928755/ |
_version_ |
1612059886923808768 |